{"id":"W4398251954","doi":"10.1093/ndt/gfae069.716","title":"#2267 IL-33 Inhibition with tozorakimab for diabetic kidney disease: a randomized, placebo-controlled phase 2b study","year":2024,"lang":"en","type":"article","venue":"Nephrology Dialysis Transplantation","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Placebo; Medicine; Internal medicine; Phase (matter); Randomized controlled trial; Chemistry; Alternative medicine; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001105462,0.0004844155,0.001385071,0.0005193209,0.0003913111,0.00007784452,0.0001573115,0.0003420752,0.0002209008],"category_scores_gemma":[0.0001940683,0.0003675808,0.0004985283,0.0004084734,0.0003873197,0.0003051891,0.00001193314,0.000343824,0.0002159144],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006116706,"about_ca_system_score_gemma":0.0003589228,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005820511,"about_ca_topic_score_gemma":0.0001855674,"domain_scores_codex":[0.9964169,0.001202499,0.0008013588,0.0008441888,0.000118134,0.0006168802],"domain_scores_gemma":[0.9977464,0.001449882,0.0001933535,0.0003339216,0.0001657842,0.0001106275],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8765192,0.002079056,0.0002517513,0.0005909891,0.005874699,0.0002299877,0.008260145,0.0001686216,0.09988052,0.00149761,0.001997355,0.002650085],"study_design_scores_gemma":[0.9521024,0.002436125,0.0002660612,0.000187764,0.0176758,0.00008388588,0.0003423884,0.001226693,0.01091233,0.001019223,0.01298736,0.0007600373],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.952961,0.001002076,0.0286393,0.0006387655,0.0008514361,0.005656691,0.009500237,0.0004245603,0.0003259618],"genre_scores_gemma":[0.9873263,0.0003920574,0.0001042836,0.0007482745,0.0001804559,0.003809862,0.006863197,0.00005927347,0.000516352],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08896819,"threshold_uncertainty_score":0.9998776,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008055155863904014,"score_gpt":0.2479530375349654,"score_spread":0.2398978816710614,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}